The possible role of HSPs on Behçet's disease: A bioinformatic approach

Computers in Biology and Medicine

Volumn 42, Issue 11, 2012, Pages 1079-1085

  Ghasemi, Younes ^a,b   Dabbagh, Fatemeh ^a,b   Rasoul Amini, Sara ^a,b   Borhani Haghighi, Afshin ^c   Morowvat, Mohammad Hossein ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoimmunity; Beh et's disease; Bioinformatics analysis; Heat shock protein (HSP); Immunoinformatics

Indexed keywords

AMINO ACID SEQUENCE; AUTOANTIGENS; AUTOIMMUNITY; BIOINFORMATICS ANALYSIS; BIOINFORMATICS TOOLS; CONSERVED PROTEINS; CROSS-REACTIVITY; HEAT SHOCK PROTEIN; HOST TISSUES; HUMAN BEING; HUMORAL REACTIONS; IMMUNE RESPONSE; IMMUNOINFORMATICS; MOLECULAR MIMICRY; SEQUENCE HOMOLOGY; SEQUENCE SIMILARITY;

AMINO ACIDS; PROTEINS; TISSUE;

BIOINFORMATICS;

BACTERIAL PROTEIN; CHAPERONIN 60; HEAT SHOCK PROTEIN 65; TOLL LIKE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BEHCET DISEASE; BIOINFORMATICS; CELLULAR IMMUNITY; COMMENSAL; CROSS REACTION; DISEASE COURSE; HUMAN; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BASE SEQUENCE; BEHCET SYNDROME; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; FUNGAL PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS); EUKARYOTA; PROKARYOTA;

EID: 84867692604     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2012.08.009     Document Type: Article

References (73)

1. Verity D.H., Wallace G.R., Vaughan R.W., Stanford M.R. Behcet's Disease: from hippocrates to the third millennium. Br. J. Ophthalmol. 2003, 87:1175-1183.
2. Direskeneli H. Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann. Rheum. Dis. 2001, 60:996-1002.
3. Evereklioglu C. Current concepts in the etiology and treatment of Behçet's disease. Surv. Ophthalmol. 2005, 50:297-350.
4. Mumcu G., Inanc N., Yavuz S., Direskeneli H. The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease. Clin. Exp. Rheumatol. 2007, 25:S27-33.
5. Amoura Z., Guillaume M., Caillat-Zucman S., Wechsler B., Piette J.C. Pathophysiology of Behçet's disease [Physiopathologie De La Maladie De Behcet]. Rev. Med. Interne 2006, 27:843-853.
6. Mandal K., Jahangiri M., Xu Q. Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun. Rev. 2004, 3:31-37.
7. Zouboulis C.C. HLA-Independent antibacterial host response toward Th1 immunity mediated by IL-12: a new concept for the pathogenesis of Adamantiades-Behçet's disease. J. Invest. Dermatol. 2006, 126:1444-1447.
8. Direskeneli H., Saruhan-Direskeneli G. The role of heat shock proteins in Behçet's disease. Clin. Exp. Rheumatol. 2003, 4(Suppl. 30):S44-S48.
9. Hauet-Broere F., Wieten L., Guichelaar T., Berlo S., van der Zee R., Van Eden W. Heat shock proteins induce T cell regulation of chronic inflammation. Ann. Rheum. Dis. 2006, 65(Suppl III):iii65-iii68.
10. Lancaster G.I., Febbraio M.A. Mechanisms of stress-induced cellular HSP72 release. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, Springer, Dordrecht, The Netherlands, pp. 31-37. A.A.A. Asea, A. De Maio (Eds.).
11. Habich C., Burkart V. Interaction of heat shock protein 60 with innate immune cells. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, Springer, Dordrecht, The Netherlands, pp. 115-128. A.A.A. Asea, A. De Maio (Eds.).
12. Kim H. Diagnostic significance of antibodies to heat shock proteins. Clin. Chim. Acta 2003, 337:1-10.
13. Delneste Y., Jaillon S., Jeannin P. Heat shock proteins and scavenger receptors. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, Springer, Dordrecht, The Netherlands, pp. 75-94. A.A.A. Asea, A. De Maio (Eds.).
14. Williams J.H.H., Hunter-Lavin C. Roles of Extracellular heat shock proteins: a new sense of danger. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, Springer, Dordrecht, The Netherlands, pp. 39-57. A.A.A. Asea, A. De Maio (Eds.).
15. Multhoff G. HSP70 peptide acting as a danger signal for Natural Killer (NK) cells. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, Springer, Dordrecht, The Netherlands, pp. 21-30. A.A.A. Asea, A. De Maio (Eds.).
16. Gül A. Standard and novel therapeutic approaches to Behçet's disease. Drugs 2007, 67:2013-2022.
17. Mizushima Y., Hoshi K., Matsuda T., Takahashi M., Takada H., Kuribayashi S., Hamada S., Hashimoto T., Takeuchi A., Ichikawa Y., Arimori S., Ujihara H., Miyanaga Y., Kogure M., Wakatsuki F., Ohno S., Sasamoto Y. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease - a multicenter study. J. Rheumatol. 1989, 16:506-511. (The Behçet's Disease Research Committee of Japan).
18. Lund P.A., Large A.T., Kapatai G. The chaperonins: perspectives from the Archaea. Biochem. Soc. Trans. 2003, 31:681-685.
19. Saruhan-Direskeneli G., Çelet B., Eksioglu-Demiralp E., Direskeneli H. Human HSP 60 peptide responsive T cell lines are similarly present in Both Behçet's disease patients and healthy controls. Immunol. Lett. 2001, 79:203-208.
20. Shaker O., Ay El-Deen M.A., El Hadidi H., Grace B.D., El Sherif H., Abdel Halim A. The role of heat shock protein 60, vascular endothelial growth factor and antiphospholipid antibodies in Behçet's disease. Br. J. Dermatol. 2007, 156:32-37.
21. Yavuz S., Elbir Y., Tulunay A., Eksioglu-Demiralp E., Direskeneli H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet disease etiopathogenesis. Rheumatol. Int. 2008, 28:401-406.
22. Kirino Y., Takeno M., Watanabe R., Murakami S., Kobayashi M., Ideguchi H., Ihata A., Ohno S., Ueda A., Mizuki N., Ishigatsubo Y. Association of reduced heme oxygenase-1 with excessive toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease. Arthritis Res. Ther. 2008, 10:R16.
23. Imamura Y., Kurokawa M.S., Yoshikawa H., Nara K., Takada E., Masuda C., Tsukikawa S., Ozaki S., Matsuda T., Suzuki N. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease. Clin. Exp. Immunol. 2005, 139:371-378.
24. Meguro A., Ota M., Katsuyama Y., Oka A., Ohno S., Inoko H., Mizuki N. Association of the toll-like receptor 4 gene polymorphisms with Behçet's disease. Ann. Rheum. Dis. 2008, 67:725-727.
25. Durai M., Huang M.N., Moudgil K.D. Self Heat-Shock protein 65-mediated regulation of autoimmune arthritis. J. Autoimmun. 2009, 33:208-213.
26. Van Eden W. Heat shock proteins are targets for T cell regulation: how microbial Hsp induce IL10 producing anti-inflammatory T cells. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, Springer, Dordrecht, The Netherlands, pp. 289-308. A.A.A. Asea, A. De Maio (Eds.).
27. Fortune F., Walker J., Lefrancois M., Lehner T. The expression of carbohydrate antigens in activated T cells and in autoimmune diseases. Scand. J. Immunol. 1994, 40:636-642.
28. Sakane T., Suzuki N., Nagafuchi H. Etiopathology of Behcet's disease: immunological aspects. Yonsei Med. J. 1997, 38:350-358.
29. Direskeneli H. Autoimmunity vs autoinflammation in Behçet's disease: do we oversimplify a complex disorder?. Rheumatology 2006, 45(12):1461-1465.
30. Direskeneli H., Eksioglu-Demiralp E., Yavuz S., Ergun T., Shinnick T., Lehner T., Akoglu T., Cell T Responses to 60/65kDa heat shock protein derived peptides in turkish patients with Behçet's disease. J. Rheumatol. 2000, 27:708-713.
31. Escudier M., Bagan J., Scully C. Mucosal diseases series: number VII Behçet's disease (Adamantiades syndrome). Oral Dis. 2006, 12:78-84.
32. Gaston J.S.H., Hasan A., Fortune F., Wilson A., Lehner T. Role of γδ T cells in Behçet's disease. Lancet 1996, 347:1631-1632.
33. Kaneko S., Suzuki N., Yamashita N., Nagafuchi H., Nakajima T., Wakisaka S., Yamamoto S., Sakane T. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (HSP) in patients with Behçet's disease (BD) in Japan. Clin. Exp. Immunol. 1997, 108:204-212.
34. Lehner T., Lavery E., Smith R., Van Der Zee R., Mizushima Y., Shinnick T. Association between the 65-Kilodalton heat shock protein, Streptococcus Sanguinis, and the corresponding antibodies in Behçet's syndrome. Infect. Immun. 1991, 59:1434-1441.
35. Pervin K., Childerstone A., Shinnick T., Mizushima Y., Van der Zee R., Hasan A., Vaughan R., Lehner T., Cell Epitope T Expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J. Immunol. 1993, 151:2273-2282.
36. Uchio E., Stanford M., Hasan A., Satoh S., Ohno S., Shinnick T., Van Der Zee R., Mizushima Y., Lehner T. HSP-derived peptides inducing uveitis and IgG and IgA antibodies. Exp. Eye Res. 1998, 67:719-727.
37. Tanaka T., Yamakawa N., Koike N., Suzuki J., Mizuno F., Usui M. Behçet's disease and antibody titers to various heat-shock protein 60s. Ocul. Immunol. Inflamm. 1999, 7:69-74.
38. Kaneko F., Oyama N., Yanagihori H., Isogai E., Yokota K., Oguma K. The role of streptococcal hypersensitivity in the pathogenesis of Behçet's disease. Eur. J. Dermatol. 2008, 18(5):489-498.
39. Tsuchida M., Mineshita S., Okonogi H., Sugimor K., Hoshi K., Horiuchi T., Wang L., Fujimoto E.K. The role of an uncommon type of oral Streptococcus sanguis in the etiology of Behçet's disease. Environ. Health Prev. Med. 1997, 2:59-63.
40. Fresko I., Ugurlu S., Ozbakir F., Celik A., Yurdakul S., Hamuryudan V., Yazici H. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clin. Exp. Rheumatol. 2005, 23(38):S67-S70.
41. Krause I., Monselise Y., Milo G., Weinberger A. Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease. Clin. Exp. Rheumatol. 2002, 20(Suppl. 26):S21-S24.
42. Avc O., Ellidokuz E., Simsek I., Büyükgebiz B., Güne A.T. Helicobacter pylori and Behçet's disease. Dermatology 1999, 199:140-143.
43. Ayaslioglu E., Düzgün N., Erkek E., Inal A. Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease. Scand. J. Infect. Dis. 2004, 36:428-430.
44. di Meo N., Quaranta L., Crisman G., Trevisan G. Adamantiades Behçet disease triggered by a tick bite and or Borrelia infection. J. Eur. Acad. Dermatol. Venereol. 2009, 23:1198-1199.
45. Gündüz A., Gündüz A., Cumurcu T., Seyrek A. Conjunctival flora in Behçet patients. Can. J. Ophthalmol. 2008, 43:476-479.
46. Hatemi G., Bahar H., Uysal S., Mat C., Gogus F., Masatlioglu S., Altas K., Yazici H. The pustular skin lesions in Behçet's syndrome are not sterile. Ann. Rheum. Dis. 2004, 63:1450-1452.
47. Iliopoulos A., Kedikoglou S., Laxanis S., Kourouklis S., Katsaros E. A case of tuberculous meningoencephalitis in a patient with Behçet's disease. Clin. Rheumatol. 2005, 25:121-122.
48. Isogai E., Isogai H., Kotake S., Ohno S., Kimura K., Oguma K. Role of Streptococcus sanguis and traumatic factors in Behçet's disease. J. Appl. Res. Clin. Exp. Ther. 2003, 3(1):64-75.
49. Isogai E., Isogai H., Kotake S., Yoshikawa K., Ichiishi A., Kosaka S., Sato N., Hayashi S., Oguma K., Ohno S. Detection of antibodies against Borrelia burgdorferi in patients with uveitis. Am. J. Ophthalmol. 1991, 112(1):23-30.
50. Namba K., Ueno T., Okita M. Behçet's disease and streptococcal infection. Jpn. J. Ophthalmol. 1986, 30(4):385-401.
51. Narikawa S., Suzuki Y., Takahashi M., Furukawa A., Sakane T., Mizushima Y. Streptococcus oralis previously identified as uncommon 'Streptococcus sanguis' in Behçet's disease. Arch. Oral Biol. 1995, 40(8):685-690.
52. Oh S.H., Lee K.Y., Lee J.H., Bang D. Clinical manifestations associated with high titer of anti-streptolysin O in Behçet's disease. Clin. Rheumatol. 2008, 27:999-1003.
53. Suga Y., Tsuboi R., Kobayashi S., Ogawa H. A case of Behçet's disease aggravated by gingival infection with methicillin-resistant Staphylococcus aureus. Br. J. Dermatol. 1995, 133(2):319-321.
54. Yanagihori H., Oyama N., Nakamura K., Mizuki N., Oguma K., Kaneko F. Role of IL-12B promoter polymorphism in Adamantiades-Behçet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J. Invest. Dermatol. 2006, 126:1534-1540.
55. Yildirim B., Öztürk M.A., Ünal S. The anti-Helicobacter pylori Antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behçet's syndrome. Rheumatol. Int. 2009, 29:477-478.
56. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
57. Gupta R.S. Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of proteins and the origin of eukaryotic cells. Mol. Microbiol. 1995, 15(1):1-11.
58. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4:406-425.
59. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783-791.
60. Tamura K., Nei M., Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. USA 2004, 101:11030-11035.
61. Balaji S., Srinivasan N. Comparison of sequence-based and structure-based phylogenetic trees of homologous proteins: inferences on protein evolution. J. Biosci. 2007, 32:83-96.
62. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int. Rev. Immunol. 1997, 14(1):21-32.
63. Feige U., van Eden W. Infection, autoimmunity and autoimmune disease. EXS 1996, 77:359-373.
64. Yang X., Feige U. Heat shock proteins in autoimmune disease. from causative antigen to specific therapy?. Experientia 1992, 48(7):650-656.
65. Ehrenstein M., Isenberg D. Autoimmunity associated with infection: leprosy, acute rheumatic fever and lyme disease. Curr. Opin. Immunol. 1991, 3(6):930-935.
66. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity - friends or foes?. Trends Immunol. 2009, 30(8):409-414.
67. Zouboulis C.C., May T. Pathogenesis of Adamantiades-Behçet's disease. Med. Microbiol. Immunol. 2003, 192:149-155.
68. Gül A. Behçet's disease: an update on the pathogenesis. Clin. Exp. Rheumatol. 2001, 19(Suppl. 24):S6-S12.
69. Jones D.B., Coulson A.F.W., Duff G.W. Sequence homologies between Hsp60 and autoantigens. Immunol. Today 1993, 14(3):115-118.
70. Nagafuchi H., Takeno M., Yoshikawa H., Kurokawa M.S., Nara K., Takada E., Masuda C., Mizoguchi M., Suzuki N. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behçet's disease. Clin. Exp. Immunol. 2005, 139:363-370.
71. Sancak B., Önder M., Öztas M.O., Bukan N., Gürer M.A. Nitric oxide levels in Behçet's disease. J. Eur. Acad. Dermatol. Venereol. 2003, 17:7-9.
72. Miura T., Ishihara K., Kato T., Kimizuka R., Miyabe H., Ando T., Uchiyama T., Okuda K. Detection of heat shock proteins but not superantigen by isolated oral bacteria from patients with Behçet's disease. Oral Microbiol. Immunol. 2005, 20:167-171.
73. Wegner N., Wait R., Venables P.J. Evolutionarily conserved antigens in autoimmune disease: implications for an infective aetiology. Int. J. Biochem. Cell Biol. 2009, 41:390-397.